88 related articles for article (PubMed ID: 4916539)
1. Immunosuppressive therapy for the eye changes of Graves' disease.
Burrow GN; Mitchell MS; Howard RO; Morrow LB
J Clin Endocrinol Metab; 1970 Sep; 31(3):307-11. PubMed ID: 4916539
[No Abstract] [Full Text] [Related]
2. The effect of triiodothyronine on cervical lymphoid structures, thyroid activity, IgG and IgM immunoglobulin level and exophthalmos in Graves' disease.
Mahaux JE; Chamla-Soumenkoff J; Delcourt R; Nagel N; Levin S
Acta Endocrinol (Copenh); 1969 Jul; 61(3):400-6. PubMed ID: 4184992
[No Abstract] [Full Text] [Related]
3. [Malignant ophthalmopathy. Results of corticosteroid therapy associated with a cytotoxic immunosuppressive agent].
Aquino CS; Coelho JC; Tendrich M; Gonçalves Filho CA; Pinto JC; Pontes JP
AMB Rev Assoc Med Bras; 1978 Apr; 24(4):115-8. PubMed ID: 308242
[No Abstract] [Full Text] [Related]
4. [Endocrine exophthalmos].
Lavergne G; Winand R
Bull Soc Belge Ophtalmol; 1973; 163(1):1-170. PubMed ID: 4351085
[No Abstract] [Full Text] [Related]
5. [Graves-Basedow type ophthalmopathy and primary hypothyroidism].
Cathelineau G; Fribourg-Desi M
Nouv Presse Med; 1974 Sep; 3(32):1995-8. PubMed ID: 4372586
[No Abstract] [Full Text] [Related]
6. Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies.
Pinchera A; Liberti P; Martino E; Fenzi GF; Grasso L; Rovis L; Baschieri L; Doria G
J Clin Endocrinol Metab; 1969 Feb; 29(2):231-8. PubMed ID: 4179303
[No Abstract] [Full Text] [Related]
7. [Effect of prednisone in immunosuppressive dosage on the clinical course of eye changes and dynamics of LATS titer in the serum].
Nauman J; Nauman A
Pol Arch Med Wewn; 1973 May; 50(5):449-58. PubMed ID: 4740191
[No Abstract] [Full Text] [Related]
8. [Concept of endocrine ophthalmopathies].
Heberting HJ; Schwarzmann E
Z Gesamte Inn Med; 1974 Sep; 29(17):712-5. PubMed ID: 4141190
[No Abstract] [Full Text] [Related]
9. [Influence of triiodothyronine on cervical lymphoid structures, thyroid activity and exophthalmos in Basedow's disease].
Mahaux JE; Chamla-Soumenkoff J; Nagel N; Levin S
Rev Iber Endocrinol; 1968; 15(90):591-9. PubMed ID: 4180471
[No Abstract] [Full Text] [Related]
10. The eye changes of Graves' disease: overview.
Werner SC
Mayo Clin Proc; 1972 Dec; 47(12):969-74. PubMed ID: 4564711
[No Abstract] [Full Text] [Related]
11. Azathioprine in the treatment of thyroid-associated ophthalmopathy.
Perros P; Weightman DR; Crombie AL; Kendall-Taylor P
Acta Endocrinol (Copenh); 1990 Jan; 122(1):8-12. PubMed ID: 2305608
[TBL] [Abstract][Full Text] [Related]
12. [Step-by-step treatment of progressive edematous-infiltrative ophthalmopathy in Graves' disease. Results of the first stage of treatment with glucocorticoids and glucocorticoids with azathioprine].
Pilarska K; Czekalski S; Syrenicz A; Andrzejewska W; Krzystolik Z; Przerwa D; Daniel B
Endokrynol Pol; 1988; 39(5):229-36. PubMed ID: 3076562
[No Abstract] [Full Text] [Related]
13. Management of the active severe eye changes of Graves' disease.
Werner SC
Trans Am Acad Ophthalmol Otolaryngol; 1967; 71(4):631-7. PubMed ID: 6072401
[No Abstract] [Full Text] [Related]
14. Relapse of Graves' disease 23 years after treatment with radioactive iodine (131I).
Hegele RA; Volpé R
J Clin Lab Immunol; 1985 Oct; 18(2):103-5. PubMed ID: 3841162
[TBL] [Abstract][Full Text] [Related]
15. [On the anti-exophthalmic and anti-thyroid action of an imidazole derivative with trichomonacidal action: metronidazole].
Portioli I; Rocchi F; Maraini G; Pescatori A
Ann Ottalmol Clin Ocul; 1968 Dec; 94(12):1457-73. PubMed ID: 5757142
[No Abstract] [Full Text] [Related]
16. Studies on the pathogenesis of the ophthalmopathy of Graves' disease.
Kriss JP; Pleshakov V; Rosenblum AL; Holderness M; Sharp G; Utiger R
J Clin Endocrinol Metab; 1967 Apr; 27(4):582-93. PubMed ID: 6071430
[No Abstract] [Full Text] [Related]
17. What the internist should know about the ophthalmopathy of Graves' disease.
Hamburger JI; Sugar HS
Arch Intern Med; 1972 Jan; 129(1):131-9. PubMed ID: 5066655
[No Abstract] [Full Text] [Related]
18. Spontaneous reversal of vertical diplopia in Graves' eye disease.
Frueh BR; Benger RS
Trans Am Ophthalmol Soc; 1985; 83():387-96. PubMed ID: 3841699
[No Abstract] [Full Text] [Related]
19. [Influence of immunosuppressive treatment on hormonal exophthalmos].
Engelberth O; Bĕlíkovová H; Soumar J
Vnitr Lek; 1974 Dec; 20(12):1192-201. PubMed ID: 4480006
[No Abstract] [Full Text] [Related]
20. [Assessment of early immunosuppressive therapy in the prevention of complications of Graves' disease].
Huszno B; Trofimiuk M; Gołkowski F; Plinta T; Szybiński Z
Przegl Lek; 2004; 61(8):868-71. PubMed ID: 15789920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
